These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11364910)

  • 1. Drug-resistant herpes: cidofovir gel in limbo. Interview with Jay Lalezari, M.D. Interview by John S. James.
    Lalezari J
    AIDS Treat News; 1997 Nov; (No 283):5-6. PubMed ID: 11364910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir-resistant herpes: expanded access available for cidofovir gel (Forvade).
    AIDS Treat News; 1997 Feb; (No 264):5. PubMed ID: 11364104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gilead announces phase I/II data insufficient for marketing clearance of FORVADE topical gel to treat refractory herpes in patients with AIDS.
    AIDS Patient Care STDS; 1997 Aug; 11(4):293. PubMed ID: 11361852
    [No Abstract]   [Full Text] [Related]  

  • 4. Gel for resistant herpes.
    Vazquez E
    Posit Aware; 1998; 9(1):16. PubMed ID: 11364993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NDA filed to treat refractory herpes.
    AIDS Patient Care STDS; 1997 Apr; 11(2):103. PubMed ID: 11361756
    [No Abstract]   [Full Text] [Related]  

  • 6. Cidofovir use in acyclovir-resistant herpes infection.
    Martinez CM; Luks-Golger DB
    Ann Pharmacother; 1997 Dec; 31(12):1519-21. PubMed ID: 9416391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on cidofovir for CMV retinitis.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1997 May; 3(5):18-24. PubMed ID: 11364334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
    Lalezari J; Schacker T; Feinberg J; Gathe J; Lee S; Cheung T; Kramer F; Kessler H; Corey L; Drew WL; Boggs J; McGuire B; Jaffe HS; Safrin S
    J Infect Dis; 1997 Oct; 176(4):892-8. PubMed ID: 9333146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of recalcitrant human papillomavirus gingival infection with topical cidofovir.
    Calista D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):713-5. PubMed ID: 11113816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA grants marketing clearance of Vistide for the treatment of CMV retinitis.
    AIDS Patient Care STDS; 1996 Dec; 10(6):383-4. PubMed ID: 11361576
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of topical and intralesional cidofovir.
    Zabawski EJ
    Dermatol Online J; 2000 Sep; 6(1):3. PubMed ID: 11328613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local treatment of HPV-induced skin lesions by Cidofovir.
    Stragier I; Snoeck R; De Clercq E; Van Den Oord JJ; Van Ranst M; De Greef H
    J Med Virol; 2002 Jun; 67(2):241-5. PubMed ID: 11992585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of verruca vulgaris with topical cidofovir.
    Zabawski EJ; Sands B; Goetz D; Naylor M; Cockerell CJ
    JAMA; 1997 Oct; 278(15):1236. PubMed ID: 9333263
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
    De Clercq E
    Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical cidofovir is more effective than is parenteral therapy for treatment of progressive vaccinia in immunocompromised mice.
    Smee DF; Bailey KW; Wong MH; Wandersee MK; Sidwell RW
    J Infect Dis; 2004 Sep; 190(6):1132-9. PubMed ID: 15319864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical cidofovir for the treatment of dermatologic conditions: verruca, condyloma, intraepithelial neoplasia, herpes simplex and its potential use in smallpox.
    Toro JR; Sanchez S; Turiansky G; Blauvelt A
    Dermatol Clin; 2003 Apr; 21(2):301-9. PubMed ID: 12757253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new topical treatment for resistant herpes simplex infections.
    Snoeck R; Andrei G; De Clercq E; Gerard M; Clumeck N; Tricot G; Sadzot-Delvaux C
    N Engl J Med; 1993 Sep; 329(13):968-9. PubMed ID: 8395657
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.
    Blot N; Schneider P; Young P; Janvresse C; Dehesdin D; Tron P; Vannier JP
    Bone Marrow Transplant; 2000 Oct; 26(8):903-5. PubMed ID: 11081393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter phase I/II dose escalation study of single-dose cidofovir gel for treatment of recurrent genital herpes.
    Sacks SL; Shafran SD; Diaz-Mitoma F; Trottier S; Sibbald RG; Hughes A; Safrin S; Rudy J; McGuire B; Jaffe HS
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2996-9. PubMed ID: 9797239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.